270 related articles for article (PubMed ID: 24316884)
1. [Treatment of testicular cancer].
Droz JP; Boyle H; Culine S; Fizazi K; Fléchon A; Massard C
Bull Cancer; 2013 Dec; 100(12):1319-32. PubMed ID: 24316884
[TBL] [Abstract][Full Text] [Related]
2. Contemporary management of postchemotherapy testis cancer.
Daneshmand S; Albers P; Fosså SD; Heidenreich A; Kollmannsberger C; Krege S; Nichols C; Oldenburg J; Wood L
Eur Urol; 2012 Nov; 62(5):867-76. PubMed ID: 22938868
[TBL] [Abstract][Full Text] [Related]
3. High-dose chemotherapy and stem-cell rescue for metastatic germ-cell tumors.
Einhorn LH; Williams SD; Chamness A; Brames MJ; Perkins SM; Abonour R
N Engl J Med; 2007 Jul; 357(4):340-8. PubMed ID: 17652649
[TBL] [Abstract][Full Text] [Related]
4. [Urologic treatment of testicular germ cell cancer].
Fernández Gómez JM; Escaf Barmadah S; Guate Ortiz JL; Martín Huescar A; Fresno Forcelledo F; García Rodríguez J; Rodríguez Faba O; Jalón Monzón A; Rodríguez Martínez JJ
Arch Esp Urol; 2002 Oct; 55(8):927-36. PubMed ID: 12455283
[TBL] [Abstract][Full Text] [Related]
5. The clinical features and management of testicular germ cell tumours in patients aged 60 years and older.
Wheater MJ; Manners J; Nolan L; Simmonds PD; Hayes MC; Mead GM
BJU Int; 2011 Dec; 108(11):1794-9. PubMed ID: 21627751
[TBL] [Abstract][Full Text] [Related]
6. Treatment of patients with relapsed and/or cisplatin-refractory metastatic germ cell tumours: an update.
Koychev D; Oechsle K; Bokemeyer C; Honecker F
Int J Androl; 2011 Aug; 34(4 Pt 2):e266-73. PubMed ID: 21790652
[TBL] [Abstract][Full Text] [Related]
7. The use of dose-intensified chemotherapy in the treatment of metastatic nonseminomatous testicular germ cell tumors. German Testicular Cancer Study Group.
Bokemeyer C; Harstrick A; Beyer J; Metzner B; Rüther U; Hartmann JT; Holstein K; Derigs HG; de Wit R; Casper J; Schöffski P; Kührer I; Illiger HJ; Kempf B; Reichle A; Föller A; Hossfeld DK; Fischer JT; Berdel WE; Gerhartz HH; Kirchner H; Pflüger KH; Ostermann H; Kanz L; Schmoll HJ
Semin Oncol; 1998 Apr; 25(2 Suppl 4):24-32; discussion 45-8. PubMed ID: 9578059
[TBL] [Abstract][Full Text] [Related]
8. Current management of stage I testicular non-seminomatous germ cell tumours.
Pectasides D; Pectasides E; Constantinidou A; Aravantinos G
Crit Rev Oncol Hematol; 2009 May; 70(2):114-23. PubMed ID: 18805019
[TBL] [Abstract][Full Text] [Related]
9. Late relapse (>2 years) on surveillance in stage I non-seminomatous germ cell tumours; predominant seminoma only histology.
Nolan L; Wheater M; Kirby J; Simmonds P; Mead G
BJU Int; 2010 Dec; 106(11):1648-51. PubMed ID: 20735393
[TBL] [Abstract][Full Text] [Related]
10. Management of recurrent testicular germ cell tumors.
Sonpavde G; Hutson TE; Roth BJ
Oncologist; 2007 Jan; 12(1):51-61. PubMed ID: 17227900
[TBL] [Abstract][Full Text] [Related]
11. Management of patients with clinical stage I nonseminomatous testicular germ cell tumours: active surveillance versus primary chemotherapy versus nerve sparing retroperitoneal lymphadenectomy.
Heidenreich A; Pfister D
Arch Esp Urol; 2012 Mar; 65(2):215-26. PubMed ID: 22414450
[TBL] [Abstract][Full Text] [Related]
12. Repeat retroperitoneal lymph-node dissection after chemotherapy for metastatic testicular germ cell tumour.
Willis SF; Winkler M; Savage P; Seckl MJ; Christmas TJ
BJU Int; 2007 Oct; 100(4):809-12. PubMed ID: 17711512
[TBL] [Abstract][Full Text] [Related]
13. [Germ cell tumors of the testis].
Krainer M; Kührer I; Kratzik C
Wien Klin Wochenschr; 1994; 106(2):37-44. PubMed ID: 8146994
[TBL] [Abstract][Full Text] [Related]
14. Management of residual non-retroperitoneal disease following chemotherapy for germ cell tumor.
Sadeghi N; Badalato GM; Kates M; McKiernan JM
Urol Oncol; 2011; 29(6):837-41. PubMed ID: 21489835
[TBL] [Abstract][Full Text] [Related]
15. High-dose chemotherapy with autologous stem cell support in patients with metastatic non-seminomatous testicular cancer - a report from the Swedish Norwegian Testicular Cancer Group (SWENOTECA).
Haugnes HS; Laurell A; Stierner U; Bremnes RM; Dahl O; Cavallin-Ståhl E; Cohn-Cedermark G
Acta Oncol; 2012 Feb; 51(2):168-76. PubMed ID: 22175254
[TBL] [Abstract][Full Text] [Related]
16. Promising novel therapies for relapsed and refractory testicular germ cell tumors.
Kozakova K; Mego M; Cheng L; Chovanec M
Expert Rev Anticancer Ther; 2021 Jan; 21(1):53-69. PubMed ID: 33138660
[TBL] [Abstract][Full Text] [Related]
17. [Management of metastatic testicular germ cell tumors].
Lavaud P; Baciarello G; Fizazi K
Bull Cancer; 2019 Oct; 106(10):896-902. PubMed ID: 31466695
[TBL] [Abstract][Full Text] [Related]
18. Testicular germ cell tumors. Current concepts and management strategies.
Cost NG
Minerva Urol Nefrol; 2013 Jun; 65(2):133-55. PubMed ID: 23703101
[TBL] [Abstract][Full Text] [Related]
19. Management of advanced germ-cell tumors of the testis.
Fléchon A; Rivoire M; Droz JP
Nat Clin Pract Urol; 2008 May; 5(5):262-76. PubMed ID: 18398406
[TBL] [Abstract][Full Text] [Related]
20. Current concepts in risk factor assessment for advanced germ cell cancer.
Garzotto M; Nichols CR
Semin Urol Oncol; 2001 Aug; 19(3):165-9. PubMed ID: 11561983
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
